Specifications

Peptide salt form in an RFQ: TFA vs acetate and why it changes the labeled amount

A B2B buyer's guide to peptide counterions: what TFA and acetate salt forms are, how they affect net peptide content and labeled mg, and what to write into an RFQ.

BatchVerity operations2026-11-127 min

Two quotes for “the same peptide, same mg, same purity” can describe different products if one is a TFA salt and the other is an acetate salt. The counterion changes what the weighed powder contains, how much of that weight is the peptide itself, and which documents you should ask for. This guide explains what to specify before you compare prices.

This article is for wholesalers, brands, and laboratory procurement teams writing specifications or RFQs. It is educational procurement guidance, not medical, legal, or end-use advice. All products discussed are supplied for research use only.

What a peptide “salt form” is

Synthetic peptides are usually isolated with charged groups that are paired with small counter-ions. The counterion is not part of the peptide sequence, but it is part of the solid material in the vial.

  • TFA salt (trifluoroacetate). Trifluoroacetic acid is widely used in solid-phase peptide synthesis and in reverse-phase HPLC purification. A peptide that is purified and lyophilized without a further exchange step is commonly supplied as a TFA salt.
  • Acetate salt. Many buyers specify acetate instead. Reaching an acetate form normally requires an additional ion-exchange or re-purification step after synthesis, which adds processing time and cost.
  • Other forms. Hydrochloride (HCl) and other salt forms exist. If you need one, it must be named in the specification, not assumed.

The salt form is a specification choice. Neither form is “better” in the abstract; what matters is that the buyer and supplier agree on which one is being quoted, made, and tested.

Why salt form changes the labeled amount

A vial label such as “10 mg” can mean two different things:

What “10 mg” may refer to What is in the vial
10 mg of gross powder (peptide + counterion + residual water) Less than 10 mg of the peptide itself
10 mg of net peptide More than 10 mg of total solid, because counterion and water are added on top

The share of the powder that is actually peptide is the net peptide content. Counterions and residual moisture make up much of the rest. Because a peptide with many basic residues can carry several counterions per molecule, the gap between gross weight and net peptide can be significant, and it differs between salt forms of the same sequence.

This is also why HPLC purity does not answer the question. A 99% HPLC result describes the relative purity of the peptide signal under one method; counterions and water are generally not reported in that percentage. For the wider distinction, see 99% peptide purity does not mean the vial contains the labeled amount and how to read the HPLC chromatogram and mass spec data on a peptide COA.

How salt form shows up in quotes

When two suppliers quote very different prices for what looks like the same item, salt form is one of the first things to check:

  • A TFA-salt quote may skip the exchange step, so it can be cheaper and faster.
  • An acetate quote may include the exchange step and the extra yield loss that comes with it.
  • One quote may define mg as gross powder and the other as net peptide.

None of these is automatically wrong. The problem is comparing them as if they were identical. For a full comparison framework, see how to compare peptide wholesale quotes.

What to write into the RFQ

State the salt form and the basis of the labeled amount explicitly. A short block like the one below removes most of the ambiguity:

  1. Sequence and name of the peptide, as you want it on documents.
  2. Salt form required: TFA, acetate, HCl, or “supplier standard — please state”.
  3. Labeled amount basis: gross powder weight or net peptide content.
  4. Purity requirement and method: for example, HPLC area % under the stated method.
  5. Identity requirement: mass spectrometry result against the expected mass.
  6. Content testing: whether you need net peptide content reported (for example by amino acid analysis or another method the laboratory states).
  7. Counterion reporting: whether you want residual TFA or acetate content reported on the COA, and by which method.
  8. Quantity, packaging format, and lot requirements, so the salt form is tied to a specific lot.

If you do not have a preference, ask the supplier to state its standard salt form in writing in the quote. That way the price, the product, and the COA all refer to the same thing. Our BPC-157 B2B documentation and quotation checklist shows how these fields fit into a complete quotation request.

What to check on the COA

When the report arrives, check that it matches the specification you sent:

  • Salt form named on the report. If the RFQ said acetate, the COA should not be silent on salt form.
  • Molecular weight basis. The expected mass used for identity normally refers to the free peptide; the report should be internally consistent about which basis it uses.
  • Net peptide content, if requested. If you asked for it, it should appear with a method, not just a number.
  • Residual counterion, if requested. A stated method and result, rather than “conforms”.
  • Lot linkage. The report should identify which lot or sample was tested. A tested sample is evidence about that sample; it does not by itself prove every later lot. See one passing sample does not prove every batch.

If any of these are missing, ask before you pay the balance, not after delivery.

Common mistakes buyers make

  • Assuming “acetate” because a competitor’s label says so, without writing it into the RFQ.
  • Comparing a gross-weight quote with a net-peptide quote on price per mg.
  • Treating HPLC purity as a measure of how much peptide is in the vial.
  • Accepting a COA that does not name the salt form for a specification that required one.

How BatchVerity handles salt form

When you send an RFQ, we confirm the salt form and the labeled-amount basis in writing before quoting, and we state which tests are covered by the report you will receive. Our public reports are listed in the COA library; they are tested-sample records, and the scope of each one is stated on the record.

If you already have a specification or a competing quote, send it to us for a preliminary review. We will tell you which fields are missing or ambiguous before you compare prices.

Request a review